Provided by Tiger Trade Technology Pte. Ltd.

Quoin Pharmaceuticals

6.79
-0.1100-1.59%
Post-market: 6.810.0200+0.29%17:07 EDT
Volume:65.67K
Turnover:443.03K
Market Cap:13.64M
PE:-0.80
High:6.87
Open:6.87
Low:6.66
Close:6.90
52wk High:41.80
52wk Low:3.25
Shares:2.01M
Float Shares:1.30M
Volume Ratio:0.41
T/O Rate:5.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.5210
EPS(LYR):-14.7963
ROE:-575.73%
ROA:-114.60%
PB:3.47
PE(LYR):-0.46

Loading ...

Quoin Pharmaceuticals (QNRX) Receives a Buy from Maxim Group

TIPRANKS
·
May 08

Quoin Pharmaceuticals Q1 EPS $(1.77) Misses $(1.72) Estimate

Benzinga Earnings
·
May 07

Quoin Pharmaceuticals Provides Corporate Update and Reports First Quarter 2026 Financial Results

GlobeNewswire
·
May 07

Quoin Pharmaceuticals Ltd expected to post a loss of $1.93 a share - Earnings Preview

Reuters
·
May 05

Quoin Pharmaceuticals Initiated at Buy by LUCID CAPITAL MARKETS

Dow Jones
·
May 05

Quoin Pharmaceuticals initiated with a Buy at Lucid Capital

TIPRANKS
·
May 04

Quoin Pharma to report Q1 results, provide corporate update May 7

Reuters
·
Apr 30

Quoin Pharmaceuticals Provides Clinical And Regulatory Update For Qrx009 Topical Rapamycin Development Programs

Reuters
·
Apr 28

Quoin plans investigator-led trial of QRX009 topical rapamycin in pachyonychia congenita

Reuters
·
Apr 28

Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs

GlobeNewswire
·
Apr 28

Quoin’s QRX003 Trial Moves Forward In Rare Skin Disease, Keeping QNRX On Investor Watch

TIPRANKS
·
Apr 22

Financing Covenants Put Quoin Pharmaceuticals at Heightened Risk of Funding Shortfall and Program Delays

TIPRANKS
·
Mar 28

Quoin Pharmaceuticals Ltd : Alliance Global Partners Raises Target Price to $35 From $25

THOMSON REUTERS
·
Mar 27

Quoin Pharmaceuticals Ltd reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 26

Quoin Pharmaceuticals Q4 EPS $(1.74) Beats $(4.02) Estimate

Benzinga Earnings
·
Mar 26

Quoin Pharmaceuticals FY2025 net loss widens 76.34% to $15.8 million; cash climbs 14.85% to $18.7 million

Reuters
·
Mar 26

Press Release: Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results

Dow Jones
·
Mar 26

Market Sentiment Around Loss-Making Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX)

Simply Wall St.
·
Mar 26

Quoin Pharmaceuticals Ltd – ADR trading halted, volatility trading pause

TIPRANKS
·
Mar 25

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:33 AM

Reuters
·
Mar 25